← All stocks

TriSalus Life Sciences, Inc.

TLSI Net buying
CIK 0001826667 #3504 in the set updated 17 Sep 2026
Bought (120 mo)
$4.45M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$376.57K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$376.57K
22 of 22 sales
Net
+$4.07M
+$4.07M against sales at will

By person

22 insiders · 50 transactions
4.4×

Mary Szela holds only 4.4 times base salary in stock. $2.65M of shares against $600.92K in salary for 2025.

Salary from the company's own proxy. The shares are what Mary Szela last reported holding, valued at $2.46, the price Common Stock was last bought or sold at on the open market here, on 15 May 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Stansky Michael P
Director
$3.01M (4)
+$3.01M
1,640,420
$4.04M
+162.2%
Szela Mary T
CEO and President
$430.04K (10)
$79.38K (2)
+$350.66K
1,077,683
$2.65M
+273.6%
Frankenius Equity AB
10% owner
$250.00K (1)
+$250.00K
6,989,748
$17.19M
+13.3%
Wahlstrom Mats
Director
$221.61K (4)
+$221.61K
147,555
$362.99K
Young James Emmett
Chief Financial Officer
$163.50K (2)
+$163.50K
79,663
$195.97K
+763.5%
Murphy Sean
Director
$157.20K (2)
+$157.20K
321,721
$791.43K
+74.5%
Valle William
Director
$125.00K (1)
+$125.00K
83,241
$204.77K
Desai Arjun JJ
Director
$110.70K (1)
−$110.70K
247,127
$607.93K
+21.7%
Gordon Gary B.
Director
$64.60K (2)
+$64.60K
72,510
$178.37K
Stevens Jennifer
Chief Regulatory Officer
$59.60K (4)
−$59.60K
124,110
$305.31K
+588.3%
Marshak Richard
Chief Commercial Officer
$49.83K (5)
−$49.83K
128,319
$315.66K
+746.7%
Cox Bryan F.
Chief of Research
$39.16K (5)
−$39.16K
163,415
$402.00K
+106.5%
Devlin Jodi
Chief of Clinical Operations
$37.85K (4)
−$37.85K
97,364
$239.52K
Patience David
Chief Financial Officer
$32.25K (2)
+$32.25K
261,107
$642.32K
Martin George Kelly
Director
$49.50 (1)
−$49.50
247,176
$608.05K
0.0%
MedTech Acquisition Sponsor LLC entity
10% owner
6,249,999
$15.37M
MATLIN DAVID J
Director
1,323,210
$3.26M
HICKS KERRY R
Director
542,790
$1.34M
+5.5%
Marshall Richard Henry
Chief Medical Officer
90,000
$221.40K
+200.0%
Katz Steven C
CHIEF MEDICAL OFFICER
68,587
$168.72K
+99.1%
Magnetar Financial LLC entity
10% owner
16,668
$41.00K
−96.4%
Hyveled Liselotte
Director
10,040
$24.70K

No percentages here. This company's share count has moved by a factor of 2.0 over the window, from 30,493,137 to 61,574,600 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Gordon Gary B.
15 May 2026
Director
Buy
10,000
$2.46
$24.60K
Patience David
15 May 2026
Chief Financial Officer
Buy
7,100
$2.43
$17.25K
Szela Mary T
15 May 2026
CEO and President
Buy
39,682
$2.59
$102.78K
Stansky Michael P
15 May 2026
Director
Buy indirect
200,000
$2.50
$500.00K
Stansky Michael P
15 May 2026
Director
Buy
410,000
$2.50
$1.03M
Wahlstrom Mats
15 May 2026
Director
Buy
60,000
$2.53
$151.80K
Marshak Richard
15 May 2026
Chief Commercial Officer
Sell
543
$2.67
$1.45K
Szela Mary T
17 Mar 2026
CEO and President
Sell
15,944
$3.85
$61.38K
Stevens Jennifer
16 Mar 2026
Chief Regulatory Officer
Sell
774
$4.12
$3.19K
Marshak Richard
16 Mar 2026
Chief Commercial Officer
Sell
419
$4.12
$1.73K
Cox Bryan F.
16 Mar 2026
Chief of Research
Sell
579
$4.12
$2.39K
Devlin Jodi
16 Mar 2026
Chief of Clinical Operations
Sell
273
$4.12
$1.12K
Stevens Jennifer
12 Mar 2026
Chief Regulatory Officer
Sell
1,552
$4.09
$6.35K
Marshak Richard
12 Mar 2026
Chief Commercial Officer
Sell
1,589
$4.09
$6.50K
Cox Bryan F.
12 Mar 2026
Chief of Research
Sell
1,467
$4.09
$6.00K
Devlin Jodi
12 Mar 2026
Chief of Clinical Operations
Sell
1,772
$4.09
$7.25K
Szela Mary T
11 Mar 2026
CEO and President
Sell
4,358
$4.13
$18.00K
Stevens Jennifer
11 Mar 2026
Chief Regulatory Officer
Sell
1,204
$4.13
$4.97K
Marshak Richard
11 Mar 2026
Chief Commercial Officer
Sell
1,449
$4.13
$5.98K
Cox Bryan F.
11 Mar 2026
Chief of Research
Sell
1,138
$4.13
$4.70K
Devlin Jodi
11 Mar 2026
Chief of Clinical Operations
Sell
1,162
$4.13
$4.80K
Stansky Michael P
23 Feb 2026
Director
Buy indirect
117,198
$4.10
$480.51K
Stansky Michael P
23 Feb 2026
Director
Buy
243,900
$4.10
$999.99K
Szela Mary T
23 Feb 2026
CEO and President
Buy
30,487
$4.10
$125.00K
Valle William
23 Feb 2026
Director
Buy
30,487
$4.10
$125.00K
Gordon Gary B.
23 Feb 2026
Director
Buy
9,756
$4.10
$40.00K
Patience David
23 Feb 2026
Chief Financial Officer
Buy
3,657
$4.10
$14.99K
Stevens Jennifer
19 May 2025
Chief Regulatory Officer
Sell
8,704
$5.18
$45.09K
Marshak Richard
19 May 2025
Chief Commercial Officer
Sell
6,597
$5.18
$34.17K
Devlin Jodi
19 May 2025
Chief of Clinical Operations
Sell
4,764
$5.18
$24.68K
Cox Bryan F.
19 May 2025
Chief of Research
Sell
4,764
$5.18
$24.68K
Young James Emmett
5 Feb 2025
Chief Financial Officer
Buy indirect
6,000
$5.65
$33.90K
Szela Mary T
30 Jan 2025
CEO AND PRESIDENT
Buy
5,010
$5.28
$26.45K
Szela Mary T
29 Jan 2025
CEO AND PRESIDENT
Buy
5,030
$5.03
$25.30K
Murphy Sean
28 Jan 2025
Chief Manuf, Strategy&Bus Dev.
Buy indirect
15,000
$5.17
$77.55K
Szela Mary T
28 Jan 2025
CEO AND PRESIDENT
Buy
4,716
$5.12
$24.15K
Young James Emmett
27 Jan 2025
Chief Financial Officer
Buy indirect
24,000
$5.40
$129.60K
Murphy Sean
27 Jan 2025
Chief Manuf, Strategy&Bus Dev.
Buy indirect
15,000
$5.31
$79.65K
Szela Mary T
27 Jan 2025
CEO AND PRESIDENT
Buy
4,826
$5.42
$26.16K
Frankenius Equity AB
17 Dec 2024
10% owner
Buy
62,972
$3.97
$250.00K
Desai Arjun JJ
10 Dec 2024
Director
Sell
30,000
$3.69
$110.70K
Wahlstrom Mats
22 Nov 2024
Director
Buy
5,000
$4.55
$22.75K
Wahlstrom Mats
21 Nov 2024
Director
Buy
8,687
$4.44
$38.57K
Wahlstrom Mats
20 Nov 2024
Director
Buy
2,040
$4.16
$8.49K
Cox Bryan F.
5 Oct 2024
CHIEF SCIENTIFIC & MANUFACT.
Sell
314
$4.44
$1.39K
Szela Mary T
13 Sep 2024
CEO AND PRESIDENT
Buy
6,000
$5.00
$30.00K
Szela Mary T
13 Sep 2024
CEO AND PRESIDENT
Buy
1,295
$4.83
$6.25K
Szela Mary T
12 Sep 2024
CEO AND PRESIDENT
Buy
7,520
$5.20
$39.10K
Szela Mary T
10 Sep 2024
CEO AND PRESIDENT
Buy
5,000
$4.97
$24.85K
Martin George Kelly
28 Aug 2024
Director
Sell indirect
9
$5.50
$49.50

What was left out

Form 4 filings counted 122
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 22
Transactions with no price 0
Shares from compensation/vesting 10,800,096
History held since 28 Dec 2020